| __timestamp | Protagonist Therapeutics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 1860000 | 381287000 |
| Thursday, January 1, 2015 | 2963000 | 452612000 |
| Friday, January 1, 2016 | 6961000 | 316800000 |
| Sunday, January 1, 2017 | 11779000 | 330100000 |
| Monday, January 1, 2018 | 13697000 | 265800000 |
| Tuesday, January 1, 2019 | 15749000 | 336200000 |
| Wednesday, January 1, 2020 | 18638000 | 423900000 |
| Friday, January 1, 2021 | 27196000 | 467000000 |
| Saturday, January 1, 2022 | 31739000 | 487000000 |
| Sunday, January 1, 2023 | 33491000 | 477100000 |
Unlocking the unknown
In the competitive world of biotechnology, understanding financial trends is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of United Therapeutics Corporation and Protagonist Therapeutics, Inc. from 2014 to 2023. Over this period, United Therapeutics consistently outspent Protagonist Therapeutics, with expenses peaking at approximately $487 million in 2022, a 30% increase from 2014. In contrast, Protagonist Therapeutics saw a more dramatic rise, with expenses growing nearly 18-fold, from $1.86 million in 2014 to $33.5 million in 2023. This stark contrast highlights the differing scales and growth trajectories of these companies. United Therapeutics' steady increase reflects its established market presence, while Protagonist's rapid growth underscores its aggressive expansion strategy. These insights provide a window into the strategic priorities and operational scales of these two biotech players.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc.
United Therapeutics Corporation vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Verona Pharma plc
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Alkermes plc
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
PTC Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: MorphoSys AG vs Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Protagonist Therapeutics, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Dynavax Technologies Corporation
Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Celldex Therapeutics, Inc.